Emerging Contract Research Organization Gains Electronic Data Capture Capabilities to More Efficiently Capture and Process Clinical Trial Data
Redwood Shores, CA-April 13, 2009
News Facts
·
JSS Medical Research
, a full-service contract research organization (CRO) headquartered in Montreal, has deployed Oracle® Health Sciences applications including
Oracle Clinical
,
Oracle Remote Data Capture
, and
Oracle Thesaurus Management System
to support its expansion plans into the global clinical trials market.
· JSS Medical Research plans to use the Oracle Health Sciences applications to support its business unit focused on clinical trial data management.
· The emerging CRO expects to launch its first Oracle Clinical-supported study this month and plans to use Oracle Clinical to manage data for all of its new studies by the end of 2009.
· JSS Medical Research offers services covering the entire spectrum of the study from conception to the dissemination of results. Its research team is comprised of clinical epidemiologists, physicians, biostatisticians, project managers and information technology experts who work together to help ensure the success of its projects.
· In order to support its strategy of expanding its presence in North America and entering the European market, JSS Medical Research required a robust, proven and highly reliable and scalable clinical data management system to replace its legacy systems that were developed in-house.
·
BioPharm Systems
, an Oracle Certified Partner, worked with JSS Medical Research to help deploy and validate the system to comply with U.S. Food and Drug Administration as well as European regulatory agency requirements.
Supporting Quotes
· “This important investment in Oracle Health Sciences applications supports JSS’ commitment to offering its international pharmaceutical, biotechnology and nutraceutical clients the highest quality Phase II to IV clinical contract research services,” said Dr. John Sampalis, President, JSS Medical Research. “Oracle’s industry-leading clinical development applications will provide a solid and scalable foundation to support our expansion into the global clinical trials market.”
· “Oracle is helping forward-thinking CROs, like JSS Medical Research, in their efforts to expand operations and capitalize on the emergence of global clinical trials,” said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences. “Oracle’s industry-leading applications help CROs to build a proven data and clinical trial management foundation which enable them to accelerate insights for better health.”
Supporting Resources
·
Oracle in Health Sciences
·
Oracle Clinical Applications
About Oracle
Oracle (NASDAQ: ORCL) is the world’s largest business software company. For more information about Oracle, please visit our Web site at
http://www.oracle.com
.
Trademark
Oracle is a registered trademark of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.
SOUL Trial Shows Oral Semaglutide Significantly Reduces Cardiovascular Risk in Type 2 Diabetes
April 3rd 2025Phase III SOUL trial shows daily oral semaglutide lowers the risk of major adverse cardiovascular events in patients with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney disease, with benefits consistent with injectable semaglutide and other GLP-1 receptor agonists.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.